APA

Wang R., Zhang Z., Kumar M., Xu G. & Zhang M. (20190809). Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3β pathway. : Drug design, development and therapy.

Chicago

Wang Ruiwei, Zhang Zihao, Kumar Mukesh, Xu Guangming and Zhang Mengyuan. 20190809. Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3β pathway. : Drug design, development and therapy.

Harvard

Wang R., Zhang Z., Kumar M., Xu G. and Zhang M. (20190809). Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3β pathway. : Drug design, development and therapy.

MLA

Wang Ruiwei, Zhang Zihao, Kumar Mukesh, Xu Guangming and Zhang Mengyuan. Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3β pathway. : Drug design, development and therapy. 20190809.